These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 28705716)

  • 41. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients].
    Ma JX; Lu HZ; Wang JR; Zhang RF; Zheng YF; Liu L; Qi TK; Shen YZ
    Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):574-7. PubMed ID: 19035170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.
    Khamduang W; Ngo-Giang-Huong N; Gaudy-Graffin C; Jourdain G; Suwankornsakul W; Jarupanich T; Chalermpolprapa V; Nanta S; Puarattana-Aroonkorn N; Tonmat S; Lallemant M; Goudeau A; Sirirungsi W;
    Clin Infect Dis; 2013 Jun; 56(12):1704-12. PubMed ID: 23487379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.
    Tandoi F; Caviglia GP; Pittaluga F; Abate ML; Smedile A; Romagnoli R; Salizzoni M
    Dig Liver Dis; 2014 Nov; 46(11):1020-4. PubMed ID: 25201211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
    Lo Re V; Frank I; Gross R; Dockter J; Linnen JM; Giachetti C; Tebas P; Stern J; Synnestvedt M; Localio AR; Kostman JR; Strom BL
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):315-20. PubMed ID: 17159655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
    Aghakhani A; Banifazl M; Kalantar E; Eslamifar A; Ahmadi F; Razeghi E; Atabak S; Amini M; Khadem-Sadegh A; Ramezani A
    Ther Apher Dial; 2010 Jun; 14(3):349-53. PubMed ID: 20609190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
    Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P
    Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia.
    Darmawan E; Turyadi ; El-Khobar KE; Nursanty NK; Thedja MD; Muljono DH
    J Med Virol; 2015 Feb; 87(2):199-207. PubMed ID: 25521058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assay.
    Akram A; Islam SMR; Munshi SU; Tabassum S
    J Viral Hepat; 2018 Nov; 25(11):1306-1311. PubMed ID: 29768691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of 'anti-HBc only' in the clinical virology laboratory.
    Alhababi F; Sallam TA; Tong CY
    J Clin Virol; 2003 Jul; 27(2):162-9. PubMed ID: 12829038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India.
    Panigrahi R; Majumder S; Gooptu M; Biswas A; Datta S; Chandra PK; Banerjee A; Chakrabarti S; Bandopadhyay D; De BK; Chakravarty R
    Ann Hepatol; 2012; 11(6):870-5. PubMed ID: 23109450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.